SEC Company Response from Q (QCLS) — Nov 15, 2016
Q/C TECHNOLOGIES, INC. (QCLS) (CIK 0001321834)
Date: Nov. 15, 2016 · CIK: 0001321834 · Accession: 0001493152-16-015109
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-214214
Letter
AKERS BIOSCIENCES, INC.
GROVE ROAD
THOROFARE, NJ 08086
November 15, 2016
VIA EDGAR
U.S. Securities & Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
Re: Akers Biosciences, Inc.
Registration Statement on Form S-3
File No. 333-214214
Ladies and Gentlemen:
In accordance with Rule 461 of the Securities Act of 1933, as amended, Akers Biosciences, Inc. (the “Company”) hereby respectfully requests that the effective date of the above-captioned Registration Statement (the “Filing”) be accelerated so that it will be declared effective at 9:00 a.m. Eastern Time on Wednesday, November 16, 2016, or as soon thereafter as possible.
* * * *
Very
Truly Yours,
Akers
Biosciences, Inc.
Show Raw Text
CORRESP
1
filename1.htm
AKERS
BIOSCIENCES, INC.
201
GROVE ROAD
THOROFARE,
NJ 08086
November
15, 2016
VIA
EDGAR
U.S.
Securities & Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Re:
Akers
Biosciences, Inc.
Registration
Statement on Form S-3
File
No. 333-214214
Ladies
and Gentlemen:
In
accordance with Rule 461 of the Securities Act of 1933, as amended, Akers Biosciences, Inc. (the “Company”) hereby
respectfully requests that the effective date of the above-captioned Registration Statement (the “Filing”) be accelerated
so that it will be declared effective at 9:00 a.m. Eastern Time on Wednesday, November 16, 2016, or as soon thereafter as possible.
*
* * *
Very
Truly Yours,
Akers
Biosciences, Inc.
/s/
John Gormally
John
Gormally
Chief
Executive Officer